Today, MAPS is announcing that the U.S. Food and Drug Administration (FDA) has agreed to MAPS’ application for an
#ExpandedAccess
program for
#MDMA
-assisted
#psychotherapy
for
#PTSD
, which will allow 50 patients to receive MDMA-assisted
#psychotherapy
.
In a recent study with 107 participants, 61% no longer qualified for
#PTSD
after three sessions of
#MDMA
-assisted psychotherapy two months following treatment. Learn more and donate:
Celebrating the birthday of Alan Watts, a profound philosopher and writer whose insightful teachings have greatly influenced the understanding of Eastern philosophy in the Western world.
Happy birthday to the late Dr. Albert Hofmann, the pioneering chemist who first synthesized
#LSD
and
#psilocybin
. Today, we honor Hofmann's monumental contributions that helped develop the field of
#psychedelic
#science
.
Happy birthday to the late Dr. Albert Hofmann, the
#psychedelic
chemist who first synthesized
#LSD
and
#psilocybin
. Today, we celebrate Dr. Hofmann and all of his monumental contributions to the field of psychedelic
#science
.
Happy birthday to the late
#AldousHuxley
(1894-1963),
#psychedelic
thought leader and author of The Doors of Perception. Today, we celebrate
#Huxley
's contributions to the destigmatization of
#psychedelics
in mainstream society!
On this day in 1943, Swiss chemist Dr.
#AlbertHofmann
first discovered the
#psychedelic
effects of lysergic acid diethylamide (
#LSD
) through unintentional exposure to the substance.
Happy
#BicycleDay
! Today is the 76th anniversary of Dr. Albert Hofmann's first intentional experience with LSD (lysergic acid diethylamide) on April 19, 1943, three days after an accidental exposure to the
#psychedelic
substance on April 16.
To finish funding FDA Phase 3 trials of MDMA-assisted psychotherapy for PTSD, MAPS needs $10 million in donations and multi-year pledges by September 10, which unlocks a $10 million grant organized by
@TFerriss
and Psychedelic Science Funders Collaborative
In remembering Dr. Roland Griffiths, we not only celebrate a monumental researcher but also a visionary who dared to tread where few had gone before. His dedication to unraveling the mysteries of the mind has opened doors for us all.
Honoring the birthday of Albert Hofmann, a revered chemist whose groundbreaking discovery of LSD transformed the field of psychopharmacology and our understanding of consciousness itself.
Happy 9/20, the annual celebration of
#psychedelic
mushrooms.
Originally created in 2015 by mushroom advocate Nicholas Reville, September 20 continues to be celebrated globally as
#MagicMushroomDay
, a date for honoring psychedelic mushrooms.
Happy
#BicycleDay
from MAPS!
Today marks the 78th anniversary of the first intentional
#LSD
experience. On April 19, 1943, Dr.
#AlbertHofmann
consumed 250μg of LSD, then rode his bicycle home from the laboratory.
Art:
@AlexGreyCoSM
79 years ago today, Dr. Albert Hofmann became the first person to intentionally consume LSD.
Today, we honor the long, turbulent journey of
#LSD
and look toward a future of responsibly integrating
#psychedelics
into society. Happy
#BicycleDay
!
On this day in 1943, Swiss chemist Dr.
#AlbertHofmann
first discovered the psychedelic effects of lysergic acid diethylamide (
#LSD
) through unintentional exposure to the substance.
MAPS' cost-effectiveness study "predicts that
#psychedelic
therapy for posttraumatic stress disorder could save each patient $100,000 over a 30-year window."
Read the full article by
@DocAustinLim
:
via Scientific American (
@SciAm
)
On this day 85 years ago, chemist Dr. Albert Hofmann synthesized lysergic acid diethylamide (LSD) at the Sandoz pharmaceutical company in Basel, Switzerland. It wasn't until April 16, 1943, when Dr. Hofmann discovered its effects by accidentally ingesting a small amount of LSD.
Monumental
#psychedelic
news! 🗞️
MAPS is proud to share the clinical research program has achieved an important milestone: a successful confirmatory Phase 3 trial of
#MDMA
-assisted therapy for posttraumatic stress disorder (PTSD).
On this day 75 years ago, Dr.
#AlbertHofmann
became the first person to intentionally experience the
#psychedelic
effects of
#LSD
. Celebrate the 75th anniversary of this historic date by joining us for
#DiscoveringLSD
: 75 Years of Experiences.
MAPS is excited to take center stage in an episode of the highly anticipated
@Netflix
series
#HowToChangeYourMind
based on the best-selling book by
@MichaelPollan
! Watch the trailer and mark your calendar for the series debut on Tuesday, July 12.
Happy birthday to the late
#AlbertHofmann
, Ph.D.!
We honor Dr. Hofmann's historic contributions to
#psychedelic
science, including his synthesis of
#LSD
from ergot fungus in 1938.
Photo: Dr. Hofmann and MAPS Founder
@RickDoblin
in the 1980s
Today in psychedelic history, Dr. Albert Hofmann discovered the
#psychedelic
effects of
#LSD
(lysergic acid diethylamide) through accidental exposure to the substance on April 16, 1943. Three days later, on April 19, 1943, Dr. Hofmann intentionally experienced the effects of LSD.
MAPS releases a public statement following the passage of all nine statewide ballot measures to reform
#drug
policies across the
#UnitedStates
, including the first measure to
#decriminalize
drug possession in Oregon with a Portugal-inspired approach.
A psychedelic happy birthday to
@PaulStamets
! 🍄
We honor Stamets for being a pioneer in the the cultivation of both edible mushrooms and psychedelic mushrooms.
Thanks to the outpouring of support from our community, we have successfully completed the $30 million Capstone Campaign which will fund the Phase 3
#ClinicalTrials
of
#MDMA
-assisted
#psychotherapy
for
#PTSD
. We couldn’t have done it without you.
#Grateful
We are thrilled to share a momentous achievement in our mission to transform mental health care: the submission of the first-ever New Drug Application (NDA) for psychedelic therapy to the FDA!
On April 16, 1943,
#chemist
Dr. Albert Hofmann became the first person to experience the
#psychedelic
effects of
#LSD
(lysergic acid diethylamide) due to unintentional exposure during the synthesis process in Basel, Switzerland.
MAPS is honored to announce the election of
@DrCarlHart
to our Board of Directors!
Dr. Hart's decades of experience have compelled him to examine how the
#WarOnDrugs
has shaped and reinforced global structural inequities.
Join us in welcoming Dr. Hart!
Now streaming:
@Netflix
's "How to Change Your Mind” series!
Based on the book by
@MichaelPollan
, Chapter 3:
#MDMA
spotlights MAPS’
#psychedelic
research with MDMA-assisted therapy. Help change minds by spreading awareness!
Happy 83rd anniversary of the first synthesis of lysergic acid diethylamide (
#LSD
)!
On this day in 1938, chemist Dr.
#AlbertHofmann
synthesized LSD from ergot fungus at
#Sandoz
Pharmaceuticals in Basel, Switzerland.
"The only thing I can say with certainty about
#MDMA
is that, for the first time in many years, my waiting room is no longer a revolving door of solemn faces; it’s alive with the possibilities of recovery."
—Scott Shannon, M.D.
via
@WIRED
Happy birthday to the late Dr. Alexander "Sasha"
#Shulgin
, Ph.D.! Today, we honor Sasha, the renowned
#psychedelic
researcher who discovered hundreds of psychoactive compounds and dedicated his life to improving the world's knowledge about psychedelics.
Happy
#BicycleDay
from MAPS!
Today marks the 80th anniversary of the first intentional
#LSD
experience. On April 19, 1943, Dr.
#AlbertHofmann
became the first person to intentionally consume LSD, then rode his bicycle home from the laboratory.
On the front page of today's
@NYTimes
,
@AndrewJacobsNYT
profiles MAPS Founder
@RickDoblin
, Ph.D., and highlights the success of MAPS' first Phase 3 study of MDMA-assisted therapy for PTSD, the results of which were published in
@NatureMedicine
today.
Celebrating the birthday of David Nichols, an esteemed chemist and pharmacologist. His expertise in synthesizing pharmaceutical-grade MDMA for MAPS-sponsored Phase 2 clinical trials has been instrumental in exploring the therapeutic potential of psychedelics.
.
@NYTimes
expands on the news of
@HopkinsMedicine
starting the Center for Psychedelic and Consciousness Research, highlighting contributions from
@TFerriss
and acknowledging organizations like MAPS for helping pave the way for the
#psychedelic
renaissance.
Happy birthday to the late Alexander "Sasha"
#Shulgin
, Ph.D., whose pioneering contributions to
#psychedelic
research, chemistry, and
#education
will continue to be felt by generations to come.
Today, CA State Senator
@Scott_Wiener
introduced
#SB519
to
#decriminalize
certain
#psychedelics
. As advisors to Sen. Wiener in development of SB 519, MAPS applauds the bill's introduction as an important first step in state reforms to punitive
#drug
laws.
To celebrate the launch of
@MichaelPollan
's new
@Netflix
documentary series about
#psychedelics
, "How To Change Your Mind," we’ve curated resources for you to host a watch party with your friends and family!
Happy birthday to the late Alexander "Sasha"
#Shulgin
, Ph.D., whose pioneering contributions to
#psychedelic
research, chemistry, and
#education
will continue to be felt by generations to come! 🎉
To finish funding Phase 3 trials of MDMA-assisted psychotherapy for PTSD through the FDA, MAPS needs to raise $10 million in
#donations
by September 10, which unlocks a $10 million grant organized by
@TFerriss
and Psychedelic Science Funders Collaborative.
In today's edition of The
@NYTimes
newspaper (page A12), the renowned publication reveals
#research
results from the first Phase 3 clinical trial of
#MDMA
-assisted therapy for
#PTSD
, sponsored by MAPS. Pick up a copy to commemorate this historic day!
On 4/16/1943, Dr.
#AlbertHofmann
discovered the
#psychedelic
effects of
#LSD
through accidental exposure to the substance. LSD is a semi-synthetic compound first developed in 1938 by Dr. Hofmann at the Sandoz pharmaceutical company in Basel, Switzerland.
Happy 87th birthday to Ann Shulgin,
#psychedelic
researcher and author. Today, we honor Ann Shulgin's monumental contributions towards the field of
#psychedelicscience
, including her work as a lay-therapist using
#MDMA
and
#2CB
as adjuncts to psychotherapy.
On this day in
#psychedelic
history, Dr. Albert Hofmann first discovered the effects of
#LSD
through unintentional exposure to the substance.
Three days later, he underwent the first intentional LSD experience, which is now celebrated as Bicycle Day!
Happy National Magic Mushroom Day!🍄
Maria Sabina, a revered Mazatec healer from Mexico, played a crucial role in introducing the Western world to the spiritual and therapeutic potential of psychedelic mushrooms.
Learn more with the link below:
Happy 90th birthday to Ann Shulgin,
#psychedelic
researcher, author, and elder. We are in appreciation and awe of Ann's decades-long dedication and historic contributions to the field of
#PsychedelicScience
!
Happy 67th
#birthday
to MAPS Founder and Executive Director
@RickDoblin
, Ph.D.! Today, we celebrate Rick's decades of dedication to
#psychedelic
science. Give Rick a birthday
#gift
by making a donation to MAPS and help make
#MDMA
a legal medicine.
Happy birthday to the late María Sabina (1894-1985), an honored
#Mazatec
curandera who practiced the ceremonial and therapeutic use of
#psilocybin
mushrooms during healing rituals for thousands of people in southern
#Mexico
.
Magic Medicine is a documentary about the first clinical trial of
#psilocybin
for
#depression
. Through following study participants and researchers, the film explores the potential benefits this treatment may have on treating mental health disorders.
The
#SantaCruz
City Council is moving forward with plans to decriminalize
#psychedelic
mushrooms. The city council voted unanimously to advance the proposal to the Public Safety Committee for review.
via
@KPIXtv
Happy birthday to the late
#AldousHuxley
(1894-1963),
#psychedelic
thought leader and author of The Doors of Perception. Today, we celebrate
#Huxley
's contributions to the destigmatization of
#psychedelics
in mainstream society!
We share the vision of a world where psychedelics are harnessed to their fullest potential and accessible to everyone equitably. This dream can become a reality much sooner with your support.
Donate today:
Today is MAPS' 33rd anniversary! MAPS was founded as a non-profit organization by
@RickDoblin
, Ph.D., on April 8, 1986, and we are proud of our achievements that continue to expand
#psychedelic
and
#marijuana
research. Thank you for your support!
As we commemorate Terrence McKenna's birthday, we honor his lasting influence in broadening the scope of human consciousness and his essential contribution to the revival of psychedelic studies.
Read his interview featured in Vol.10 of the MAPS Bulletin:
Happy 64th birthday to
@MAPS
Founder
@RickDoblin
! Today, we honor Rick—the psychedelic miracle that he is—by celebrating his discoveries, achievements, perseverance, and over three decades of dedication towards legalizing
#psychedelic
and
#marijuana
medicine. Thank you, Rick!
Phase 3 trials of
#MDMA
-assisted psychotherapy for
#PTSD
are starting in September 2018, and are the final phase of
#research
required by the FDA before deciding whether to approve MDMA as a legal prescription treatment for PTSD.
Happy birthday to the late Aldous Huxley,
#psychedelic
thought leader and author. In November 1963, Huxley requested that Laura Huxley administer LSD to him hours before his death.
Tomorrow is
#BicycleDay
, the 78th anniversary of Dr.
#AlbertHofmann
's famous bicycle ride home after becoming the first person to intentionally ingest
#LSD
.
Explore our list of
#psychedelic
events to celebrate this historic day!
@elonmusk
@insidepharma
@jimcramer
Thank you for highlighting our research into treating PTSD with MDMA-assisted therapy,
@ElonMusk
!
As a non-profit organization, MAPS relies on the generosity of charitable donors to make psychedelic therapy a legal treatment option.
Take this seriously.
Pedaling into psychedelic history 🚲✨ Today, April 19th, we celebrate Bicycle Day in honor of Albert Hofmann's legendary LSD discovery! Let's take a ride through consciousness.
MAPS wishes you a Happy Bicycle Day! Stay safe in your rides.
Results from the first MAPS-sponsored Phase 3 trial of
#MDMA
-assisted therapy for PTSD reveal that 67% of participants who received three MDMA-assisted therapy sessions no longer qualified for a PTSD diagnosis, though collection of long-term follow-up data has not been completed.
A phase 3 clinical trial shows MDMA, aka Molly or Ecstasy, helps people overcome severe PTSD when combined with therapy. 2 months after treatment with the drug, 2/3 of patients no longer qualified for a diagnosis of PTSD. In other words, they were cured.
"I’m donating $300,000 toward making MDMA-assisted therapy a legal medicine for treating PTSD, to help kick off the $10M matching grant organized by
@TFerriss
," says
@asana
Co-Founder Justin
@Rosenstein
. MAPS is beyond grateful for Rosenstein’s support.
.
@TheIntercept
publishes a letter from the U.S. Department of Health and Human Services, highlighting how "Joe Biden's administration 'anticipates' that regulators [may] approve
#MDMA
and
#psilocybin
within the next two years" for
#PTSD
and
#depression
.
Today, we celebrate the late Ann Shulgin's birthday by reflecting on her significant contributions to psychedelic education, therapy, and research that have paved the way for our present moment in the psychedelic movement.